Biocryst Pharmaceuticals reported $10.09M in Trade Creditors for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Trade Creditors Change
Adamas Pharmaceuticals ADMS:US 4.21M 1.74M
Alexion Pharmaceuticals ALXN:US $ 125.3M 6.7M
Alnylam Pharmaceuticals ALNY:US $ 40.05M 13.03M
Chemocentryx CCXI:US $ 4.41M 6.68M
Chugai Pharma 4519:JP Y 138262M 31451M
Daiichi Sankyo 4568:JP Y 265499M 1396M
Enanta Pharmaceuticals ENTA:US $ 9.54M 3.64M
Intra Cellular Therapies ITCI:US $ 12.03M 3.91M
Karyopharm Therapeutics KPTI:US $ 881K 1.43M
Mirati Therapeutics MRTX:US $ 42.92M 19.05M
Novavax NVAX:US $ 59.56M 14.43M
Ptc Therapeutics PTCT:US $ 21.46M 0.64M
Regeneron Pharmaceuticals REGN:US $ 427M 49M
Sarepta Therapeutics SRPT:US $ 44.16M 32.52M
Ultragenyx Pharmaceutical RARE:US $ 15.58M 6.22M
Vertex Pharmaceuticals VRTX:US $ 127.86M 0.33M
YTE INCY:US $ 114.51M 7.59M
Zogenix ZGNX:US $ 12.11M 1.28M